Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001;28(4):223-33.
doi: 10.1023/a:1015701232589.

Sp1 is a key regulator of the PDGF beta-receptor transcription

Affiliations

Sp1 is a key regulator of the PDGF beta-receptor transcription

C Molander et al. Mol Biol Rep. 2001.

Abstract

The mouse PDGF beta-receptor promoter is tightly controlled by NF-Y that binds to a CCAAT box located upstream of the initiation site [1, 2]. In this report, we show that Sp1 plays an essential role in the PDGF beta-receptor transcription. Within the upstream GC rich area there are two Sp1 binding sites located in close proximity to the CCAAT box. Deletion of the GC rich region resulted in a 50% decrease of the transcriptional activity of the promoter, and a complete loss of its responsiveness to over-expression of Sp1. There was an additive effect between NF-Y and Sp I in reporter activity when they were co-transfected together with the promoter-reporter construct. Furthermore, transfection of NF-Y failed to enhance transcriptional activity when the Sp1 binding sites were deleted from the promoter, suggesting an important role for Sp1 in this NF-Y controlled transcription. We have recently reported that c-Myc represses PDGF beta-receptor transcription through its interference with the transactivation activity of NF-Y [3]. In the case of p21(wafl/cip1) transcription, c-Myc was shown to repress its transcription by sequestering Sp1 [4]. However, we could not find any effect of Sp1 in the c-Myc-mediated repression on the PFDGF beta-receptor promoter, since the deletion of SpI binding sites could not attenuate the repression by c-Myc on the promoter activity.

PubMed Disclaimer

References

    1. J Biol Chem. 2001 Jan 12;276(2):1516-22 - PubMed
    1. Mol Pharmacol. 1997 Jun;51(6):963-71 - PubMed
    1. Gene. 1999 Jun 24;234(1):61-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):192-6 - PubMed
    1. Biochem J. 1998 Apr 1;331 ( Pt 1):291-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources